![Thumbnail for Pfizer and Boehringer Ingelheim discuss the importance of real-world evidence](https://clarifyhealth.com/wp-content/uploads/2021/03/life-sciences.png)
Insights for Life Sciences
Feb 1, 2023
Pfizer and Boehringer Ingelheim discuss the importance of real-world evidence
![Thumbnail for The Future of RWE in Clinical Trial Design and Recruitment](https://clarifyhealth.com/wp-content/uploads/2021/03/life-sciences.png)
Insights for Life Sciences
Dec 13, 2022
The Future of RWE in Clinical Trial Design and Recruitment
![Thumbnail for Merck, Bristol-Myers Squibb, and Clarify discuss diversity in clinical trials](https://clarifyhealth.com/wp-content/uploads/2022/02/Merck-Bristol-Myers-Squibb-and-Clarify-discuss-diversity-in-clinical-trials-1-1024x576-1.png)
Diversity, Equity, Inclusion (DEI)
Feb 10, 2022
Merck, Bristol-Myers Squibb, and Clarify discuss diversity in clinical trials
![Thumbnail for Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients](https://clarifyhealth.com/wp-content/uploads/2021/03/life-sciences.png)
Insights for Life Sciences
Feb 2, 2022